Cancer drug shows potential as treatment for muscular dystrophy
UBC researchers have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy.
UBC team discovers ‘silver bullet’ to keep medical devices free of bacteria
University of British Columbia researchers have found a ‘silver bullet’ to kill bacteria and keep them from infecting patients who have medical devices implanted.
Creating universal blood-type organs for transplant
Dr. Jayachandran Kizhakkedathu’s team and collaborators are creating universal blood-type organs for transplant.
UBC researchers lead $24 million project to treat spinal cord injury
Dr. Karen Cheung is part of the Mend the Gap project, which will develop soft gels to help regrow nerve fibres in an injured spinal cord.
Machine learning and AI used to rapidly detect sepsis, cutting risk of death dramatically
A groundbreaking advance in quickly detecting sepsis using machine learning has been pioneered by researchers in the Hancock Lab.
UBC researchers train computers to predict the next designer drugs
Research from Dr. Michael Skinnider and Dr. Leonard Foster have trained computers to predict the next designer drugs before they are even on the market, technology that could save lives.
UBC-led researchers uncover how the novel coronavirus escapes a cell’s antiviral defenses
A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 to persist and continue spreading in the human body.
Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
A drug commonly used to treat cancer can restore memory and cognitive function in mice with Alzheimer’s disease symptoms, Jefferies Lab researchers have found.
Innovative coating for blood vessels reduces rejection of transplanted organs
Researchers have found a way to reduce organ rejection following a transplant by using a special polymer to coat blood vessels on the organ to be transplanted.
Cloud computing support accelerates COVID-19 vaccine improvements
For the last 11 months, UBC biochemistry and molecular biology professor Prof. Leonard Foster and his team have been studying how SARS-CoV-2 – the virus responsible for COVID-19 – attacks the human body, in hopes of developing a more targeted vaccine with fewer side effects.